June 14, 2021 8:26 AM

Beginning Monday, June 14, 2021, the MSU Veterinary Medical Center will allow clients into the building with patients. Find details here.

Any patient presented to the MSU Small Animal Emergency Service will undergo an initial medical evaluation to determine if urgent care is needed, and whether hospitalization is warranted. The MSU Small Animal Emergency Service will only hospitalize patients that our clinicians consider to be unstable or to have life-threatening conditions.

The Abramovitch Laboratory focuses on tuberculosis research and drug discovery at Michigan State University.

Mycobacterium tuberculosis causes tuberculosis in humans and is one of the leading causes of death by an infectious disease. A signature feature of M. tuberculosis pathogenesis is that the bacterium survives inside macrophages, a host immune cell that kills many other bacteria. The goals of Dr. Abramovitch's research program are to: 1) characterize how M. tuberculosis adapts to life inside a macrophage, and 2) apply these discoveries toward the development of new drugs. To achieve these goals, his team is using genetic, genomic, and biochemical approaches to characterize new genes and proteins that enable M. tuberculosis to succeed as an intracellular pathogen. These findings are then translated into high throughput screening platforms to identify small molecule compounds that interfere with M. tuberculosis adaptation physiology. In summary, the laboratory's mission is to make basic research discoveries that jump-start the development of new drugs to treat tuberculosis.

Robert Abramovitch, PhD, studies the mechanisms of Mycobacterium tuberculosis environmental adaptation.